Logo - springer
Slogan - springer

Biomedical Sciences - Immunology | Immunogenetics - incl. option to publish open access (Press)

We’re working on a new version of this journal site - preview it now
Immunogenetics

Immunogenetics

Editor-in-Chief: Ronald E. Bontrop
Co-Editors: M. Kasahara; M. Flajnik

ISSN: 0093-7711 (print version)
ISSN: 1432-1211 (electronic version)

Journal no. 251

151,50 € Personal Rate e-only
Get Subscription

Online subscription, valid from January through December of current calendar year

Immediate access to this year's issues via SpringerLink

1 Volume(-s) with 10 issue(-s) per annual subscription

Automatic annual renewal

More information: >> FAQs // >> Policy

Editors Profiles

Editor-in-Chief 

Prof. Ronald E. Bontrop 

Biomedical Primate Research Centre, Department of Immunobiology, Rijswijk, The Netherlands

Portrait_Ronald-Bontrop_Ed_95px
Ronald Bontrop began his biochemistry studies at the University of Leiden, the Netherlands, in 1977, and joined Professor Jon van Rood's group at the Leiden University Hospital in 1983. The theme of his research was the biochemical and functional characterization of HLA class II molecules. He defended his Ph.D. thesis successfully in 1987, and in that same year he made the move to the Biomedical Primate Research Centre (BPRC) in Rijswijk, the Netherlands.
As a post-doctoral fellow, Ronald was engaged in characterizing the major histocompatibility complex of nonhuman primate species such as the chimpanzee, the rhesus macaque, and the common marmoset. In 1998, he was appointed General and Scientific Director of the BPRC.
He also has an appointment as Professor of Comparative Immunogenetics at the University of Utrecht. His main research team is currently centered on the characterization and comparative genetics of complex recognition families encoded by the immune system, with particular attention being paid to the co-evolution of pathogens and immune recognition systems.
In 1989, he initiated and organized the international symposium “The primate MHC: implications for evolution and disease”. This meeting was the first in a series that later became known as the MHC and Evolution Conferences. In addition, he is active in various international scientific societies, and was, for instance, a member and chairman of the scientific committee of the European Federation of Immunogenetics (EFI) from 2004 until 2015. He joined the Editorial Board of Immunogenetics in 1991, and became Editor-in-Chief in 1997.

Co-Editors 

Prof. Masanori Kasahara 

Hokkaido University Graduate School of Medicine, Sapporo, Japan

Portrait_Masanori-Kasahara_Ed_95px
Dr. Kasahara received his M.D. and Ph.D. in 1980 and 1984, respectively, from Hokkaido University, Sapporo, Japan, where he is currently Professor of Pathology. He was a postdoctoral fellow in Professor Jan Klein's group at the Max Planck Institute for Biology in Tűbingen, Germany, from 1984 until 1986, where he studied genetics of the MHC.
Before assuming his current position, Dr. Kasahara was Professor of Immunogenetics in the Department of Biosystems Science at the Graduate University for Advanced Studies, Hayama, Japan, from 1996 until 2004. His research interests include the role of the MHC in health and disease as well as the genetics and evolution of the immune system.

Prof. Martin F. Flajnik 

University of Maryland School of Medicine, Baltimore, USA

Portrait_Martin-Flajnik_Ed_95px
Martin Flajnik earned his Ph.D. in immunology at the University of Rochester (NY) in 1983, and completed his postdoc at the Basel (Switzerland) Institute for Immunology under Louis Du Pasquier, a pioneer in the study of comparative immunology.
Flajnik’s first faculty position was at the University of Miami School of Medicine (SOM) in the Department of Microbiology and Immunology (1988-1998), where he became an assistant professor in 1988 (since which time he has been funded by the NIH) and a full professor in 1996. He has toiled at the University of Maryland Baltimore (SOM) ever since. His research has always been focused on the evolution of adaptive immunity, and studies have included thymic education; MHC biochemistry and genetics; emergence and function of immunoglobulin (Ig) heavy and light chain isotypes; hypermutation of Ig and TCR genes; gamma/delta TCR structure and function; emergence of costimulatory molecules; the advent of lymphoid tissues and their function in selection; mucosal immunity; and single-variable domain antibodies, for which he is best known. He became a co-editor of Immunogenetics in 2001, replacing David Watkins.

For authors and editors


  • Journal Citation Reports®
    2018 Impact Factor
  • 2.492
  • Copyright Information

    Copyright Information

    Close

    Copyright Information

    For Authors

    Submission of a manuscript implies: that the work described has not been published before (except in form of an abstract or as part of a published lecture, review or thesis); that it is not under consideration for publication elsewhere; that its publication has been approved by all co-authors, if any, as well as – tacitly or explicitly – by the responsible authorities at the institution where the work was carried out.

    Author warrants (i) that he/she is the sole owner or has been authorized by any additional copyright owner to assign the right, (ii) that the article does not infringe any third party rights and no license from or payments to a third party is required to publish the article and (iii) that the article has not been previously published or licensed. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors. Transfer of copyright to Springer (respective to owner if other than Springer) becomes effective if and when a Copyright Transfer Statement is signed or transferred electronically by the corresponding author. After submission of the Copyright Transfer Statement signed by the corresponding author, changes of authorship or in the order of the authors listed will not be accepted by Springer.

    The copyright to this article, including any graphic elements therein (e.g. illustrations, charts, moving images), is assigned for good and valuable consideration to Springer effective if and when the article is accepted for publication and to the extent assignable if assignability is restricted for by applicable law or regulations (e.g. for U.S. government or crown employees).

    The copyright assignment includes without limitation the exclusive, assignable and sublicensable right, unlimited in time and territory, to reproduce, publish, distribute, transmit, make available and store the article, including abstracts thereof, in all forms of media of expression now known or developed in the future, including pre- and reprints, translations, photographic reproductions and microform. Springer may use the article in whole or in part in electronic form, such as use in databases or data networks for display, print or download to stationary or portable devices. This includes interactive and multimedia use and the right to alter the article to the extent necessary for such use.

    Authors may self-archive the Author's accepted manuscript of their articles on their own websites. Authors may also deposit this version of the article in any repository, provided it is only made publicly available 12 months after official publication or later. He/she may not use the publisher's version (the final article), which is posted on SpringerLink and other Springer websites, for the purpose of self-archiving or deposit. Furthermore, the Author may only post his/her version provided acknowledgement is given to the original source of publication and a link is inserted to the published article on Springer's website. The link must be accompanied by the following text: "The final publication is available at link.springer.com".

    Prior versions of the article published on non-commercial pre-print servers like arXiv.org can remain on these servers and/or can be updated with Author's accepted version. The final published version (in pdf or html/xml format) cannot be used for this purpose. Acknowledgement needs to be given to the final publication and a link must be inserted to the published article on Springer's website, accompanied by the text "The final publication is available at link.springer.com". Author retains the right to use his/her article for his/her further scientific career by including the final published journal article in other publications such as dissertations and postdoctoral qualifications provided acknowledgement is given to the original source of publication.

    Author is requested to use the appropriate DOI for the article. Articles disseminated via link.springer.com are indexed, abstracted and referenced by many abstracting and information services, bibliographic networks, subscription agencies, library networks, and consortia.

    For Readers

    While the advice and information in this journal is believed to be true and accurate at the date of its publication, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may have been made. The publisher makes no warranty, express or implied, with respect to the material contained herein.

    All articles published in this journal are protected by copyright, which covers the exclusive rights to reproduce and distribute the article (e.g., as offprints), as well as all translation rights. No material published in this journal may be reproduced photographically or stored on microfilm, in electronic data bases, video disks, etc., without first obtaining written permission from the publisher (respective the copyright owner if other than Springer). The use of general descriptive names, trade names, trademarks, etc., in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.

    Springer has partnered with Copyright Clearance Center's RightsLink service to offer a variety of options for reusing Springer content. For permission to reuse our content please locate the material that you wish to use on link.springer.com or on springerimages.com and click on the permissions link or go to copyright.com, then enter the title of the publication that you wish to use. For assistance in placing a permission request, Copyright Clearance Center can be connected directly via phone: +1-855-239-3415, fax: +1-978-646-8600, or e-mail: info@copyright.com.


    © Springer-Verlag Berlin Heidelberg

Services for the Journal

Alerts for this journal

 

Get the table of contents of every new issue published in Immunogenetics.